logo-loader

Successor sought to build £500mln company at SkinBioTherapeutics

Published: 09:42 18 Feb 2019 GMT

Dr Cath O'Neill, CEO of  SkinBioTherapeutics PLC (LON:SBTX), says her successor will have the skills to take the company to commercialisation.
The boss, who invented the skin care technology and the SkinBiotix repair and protect cream, tells Proactive London "it's now the job of someone else with a different skillset to build the business into a £500mln company."
O'Neill has been with life sciences company since the beginning and is looking to return to her scientific roots.

Caledonia Mining tackles 2023 challenges with optimism for 2024 as it...

Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) chief executive Mark Learmonth tells Proactive's Stephen Gunnion the company faced a challenging 2023, primarily due to poor production in the first half of the year at its core asset, the Blanket Mine in Zimbabwe, and an underperformance...

46 minutes ago